# An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of Clopidogrel

> **NCT01210339** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 58 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Esomeprazole/ASA

## Key facts

- **NCT ID:** NCT01210339
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2011-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01210339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01210339, "An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of Clopidogrel". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01210339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*